JP2024525792A5 - - Google Patents
Info
- Publication number
- JP2024525792A5 JP2024525792A5 JP2024502014A JP2024502014A JP2024525792A5 JP 2024525792 A5 JP2024525792 A5 JP 2024525792A5 JP 2024502014 A JP2024502014 A JP 2024502014A JP 2024502014 A JP2024502014 A JP 2024502014A JP 2024525792 A5 JP2024525792 A5 JP 2024525792A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- compound
- pharmaceutically acceptable
- cancer
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21306000 | 2021-07-16 | ||
| EP21306000.7 | 2021-07-16 | ||
| PCT/EP2022/069471 WO2023285465A1 (en) | 2021-07-16 | 2022-07-12 | 6h-imidazo[1,2-a]pyrrolo[2,3-e]pyridine derivatives for use in therapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024525792A JP2024525792A (ja) | 2024-07-12 |
| JP2024525792A5 true JP2024525792A5 (https=) | 2025-07-22 |
Family
ID=77126713
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024502014A Pending JP2024525792A (ja) | 2021-07-16 | 2022-07-12 | 治療に使用するための６Ｈ－イミダゾ［１，２－ａ］ピロロ［２，３－ｅ］ピリジン誘導体 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240294529A1 (https=) |
| EP (1) | EP4370516A1 (https=) |
| JP (1) | JP2024525792A (https=) |
| CN (1) | CN118234727A (https=) |
| AR (1) | AR126473A1 (https=) |
| TW (1) | TW202320753A (https=) |
| WO (1) | WO2023285465A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2024525791A (ja) * | 2021-07-16 | 2024-07-12 | サノフイ | 治療に使用するためのイミダゾ［１，２－ｂ］［１，２，４］トリアゾール誘導体 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2928922B1 (fr) * | 2008-03-21 | 2010-04-23 | Sanofi Aventis | Derives de 2-aryl-6-phenyl-imidazo°1,2-a!pyridines polysubstitues, leur preparation et leur application en therapeutique |
| FR2928924B1 (fr) * | 2008-03-21 | 2010-04-23 | Sanofi Aventis | Derives polysubstitues de 6-heteroaryle-imidazo°1,2-a! pyridines, leur preparation et leur application en therapeutique |
| FR2928923B1 (fr) * | 2008-03-21 | 2010-04-23 | Sanofi Aventis | Derives polysubstitues de 2-heteroaryl-6-phenyl-imidazo °1,2-a!pyridines, leur preparation et leur application en therapeutiques |
| FR2950344B1 (fr) * | 2009-09-18 | 2011-11-25 | Sanofi Aventis | Derives de 5-phenyl-pyrazolopyridine, leur preparation et leur aplication en therapeutique. |
| CA3084139C (en) * | 2017-11-15 | 2023-02-28 | Korea Research Institute Of Bioscience And Biotechnology | Composition for preventing or treating neurodegenerative diseases, containing diterpene-based compound |
-
2022
- 2022-07-12 EP EP22747695.9A patent/EP4370516A1/en active Pending
- 2022-07-12 US US18/578,547 patent/US20240294529A1/en active Pending
- 2022-07-12 CN CN202280059586.1A patent/CN118234727A/zh active Pending
- 2022-07-12 JP JP2024502014A patent/JP2024525792A/ja active Pending
- 2022-07-12 WO PCT/EP2022/069471 patent/WO2023285465A1/en not_active Ceased
- 2022-07-14 TW TW111126437A patent/TW202320753A/zh unknown
- 2022-07-15 AR ARP220101871A patent/AR126473A1/es not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106573902B (zh) | 氨基烷基苯并硫氮杂*衍生物及其用途 | |
| US20250313573A1 (en) | Hydroxypyridoxazepines as nrf2 activators | |
| JP6031122B2 (ja) | 抗微生物療法のための三環式ホウ素化合物 | |
| JP2019524883A5 (https=) | ||
| JP2014503574A5 (https=) | ||
| CN115605479A (zh) | 吡啶酮并嘧啶类衍生物、其制备方法及其在医药上的应用 | |
| JP2008511601A5 (https=) | ||
| JP2011517443A5 (https=) | ||
| JP2020063289A5 (https=) | ||
| JP2014524476A5 (https=) | ||
| JP2023518776A (ja) | シクロスポリン誘導体の調製 | |
| JP2024532845A5 (https=) | ||
| JP2019507776A (ja) | ピリジニルアミノピリミジン誘導体のメシル酸塩の結晶形、その製造方法及びその使用 | |
| JP2017519796A5 (https=) | ||
| JP2024502178A5 (https=) | ||
| JP2024525792A5 (https=) | ||
| JP4707393B2 (ja) | 抗癌化合物 | |
| JP2009515984A5 (https=) | ||
| JP2018505184A5 (https=) | ||
| JP3342012B2 (ja) | 新規なインドリノン誘導体，その製造及びこのものを含む製薬学的組成物 | |
| JP2020533308A5 (https=) | ||
| JP5302199B2 (ja) | ３−（１ｈ−インドル−３−イル）−４−［２−（４−メチル−ピペラジン−１−イル）−キナゾリン−４−イル］−ピロール−２，５−ジオンの結晶形態 | |
| AU2014343754B2 (en) | Metallocene derivatives with anticancer activity | |
| JP2024525791A5 (https=) | ||
| JP2009518397A5 (https=) |